Including Lynch syndrome in personalized prognostication and follow-up of stage II and III colon cancer

We read with interest the paper by Dienstmann et al. [1], in which the authors found that incorporating microsatellite instability (MSI), BRAF and KRAS mutational status to overall survival models with TNM staging increases prognostic accuracy in stage II and III colorectal cancer (CRC) patients.

http://ift.tt/2xw2TS8